Becton, Dickinson and Company BDX
$141.81▼ -0.75% 24H
Super Investor & Insider
6
Fondi che lo detengono
#93
Rank consenso
8.6%
% dei portafogli
$2.24B
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| First Eagle Investment Management · First Eagle Investment Management | 3.18% | Add 2.42% | 11,928,111 | $1.88B |
| Bill Nygren · Harris Associates | 0.47% | Reduce 21.81% | 2,222,039 | $349.4M |
| Robert Olstein · Olstein Capital Management | 1.51% | Add 3.53% | 44,000 | $6.9M |
| Hillman Capital Management · Hillman Capital Management | 1.55% | Reduce 0.15% | 14,209 | $2.2M |
| Mairs & Power · Mairs & Power | 0.01% | — | 7,119 | $1.1M |
| Jensen Investment Management · Jensen Investment Management | 0.01% | Reduce 13.92% | 2,140 | $336,472 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare systems and research institutions worldwide. Its portfolio includes medical surgical products such as needles, syringes, and…
SectorHealthcare
ExchangeNYSE
IndustryMedical Instruments & Supplies
CountryUnited States
Employees60,000
TickerBDX
Statistics
Market Cap$39.07B
Revenue (TTM)$21.84B
Net Income$1.68B
Net Margin7.7%
EPS$5.82
P/E25.72
P/S1.83
P/B1.68
EV/EBITDA9.27
ROE6.7%
Dividend Yield2.85%
Price$141.81
Data: Twelve Data · Revenue = mcap / P/S